Midazolam

1. 2026-10-19issueIssued info_card
2. 2026-10-02srcComparison between midazolam and propofol in acute phase for ventilated patients with sepsis.
3. 2026-10-02srcMidazolam: The First Water-soluble Benzodiazepine; Pharmacology, Pharmacokinetics and Efficacy in Insomnia and Anesthesia
4. 2026-10-02srcAbsolute Bioavailability of Microdosed Midazolam After Buccal Administration Is Dependent on Buccal Exposure Time.
5. 2026-10-02srcMidazolam and other benzodiazepines.
6. 2026-10-02srcA Two-way Randomized Cross-over Pharmacokinetic and Pharmacodynamic Study of an Innovative Oral Solution of Midazolam (ADV6209).
7. 2026-10-02srcBenzodiazepines for the Treatment of Seizure Clusters.
8. 2026-10-02srcThe Role of GABA Receptors in Anesthesia and Sedation: An Updated Review.
9. 2026-10-02srcTolerance and dependence following chronic alprazolam treatment in rhesus monkeys: Role of GABAA receptor subtypes.
10. 2026-10-02srcBenzodiazepine exposure induces transcriptional down-regulation of GABAA receptor alpha1 subunit gene via L-type voltage-gated calcium channel activation.
11. 2026-10-02srcIntranasal Versus Buccal Versus Intramuscular Midazolam for the Home and Emergency Treatment of Acute Seizures in Pediatric Patients: A Randomized Controlled Trial.
12. 2026-10-02srcRefractory symptoms and end of life midazolam use in cancer patients, a single center experience.
13. 2026-10-02srcSensitivity of intravenous and oral alfentanil and pupillary miosis as minimal and noninvasive probes for hepatic and first-pass CYP3A induction.
14. 2026-10-02srcPreclinical evidence for a novel pharmacotherapeutic approach for treating benzodiazepine addiction.
15. 2026-10-02srcIntramuscular Midazolam for treatment of Status Epilepticus.
16. 2026-10-02srcA critical evaluation of midazolam nasal spray for the treatment of patients with seizure clusters.
17. 2026-10-02srcClinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU (PADIS 2018)
18. 2026-10-02srcPharmacogenomics of commonly used intravenous anesthetics.
19. 2026-10-02srcTreatment of high dose of intravenous midazolam abuse: a case report.
20. 2026-10-02srcTermination of seizures in the paediatric age group, best benzodiazepine and route of administration: A network meta-analysis
21. 2026-10-02srcEffects of midazolam on high-frequency oscillations in amygdala and hippocampus of epilepsy patients.
22. 2026-10-02srcSodium oxybate versus midazolam for end-of-life continuous deep sedation: a randomised controlled trial.
23. 2026-10-02srcDexmedetomidine in combination with midazolam after pediatric cardiac surgery.
24. 2026-10-02srcGABAA receptor beta1 subunit gene polymorphisms are associated with the sedative and amnesic effects of midazolam.
25. 2026-10-02srcMidazolam: A Review of its Pharmacological Properties and Therapeutic Use
26. 2026-10-02srcPharmacokinetics of midazolam, 1'-OH-midazolam, 4-OH-midazolam, 1'-OH-midazolam-beta-D-glucuronide, and 4-OH-midazolam-beta-D-glucuronide in serum and urine from patients undergoing cardiac surgery.
27. 2026-10-02srcRemimazolam: Non-Clinical and Clinical Profile of a New Sedative/Anesthetic Agent
28. 2026-10-02srcThe history of benzodiazepines
29. 2026-10-02srcEvidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults
30. 2026-10-02srcNE contribution to rebooting unconsciousness caused by midazolam.
31. 2026-10-02srcPharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition.
32. 2026-10-02srcFlumazenil's reversal of myoclonic-like movements associated with midazolam in term newborns.
33. 2026-10-02srcFlumazenil in mixed benzodiazepine/tricyclic antidepressant overdose: a placebo-controlled study in the dog.
34. 2026-10-02srcChronic benzodiazepine administration: from the patient to the gene.
35. 2026-10-02srcEffect of voriconazole on the pharmacokinetics and pharmacodynamics of intravenous and oral midazolam.
36. 2026-10-02srcFlumazenil. A reappraisal of its pharmacological properties and therapeutic efficacy as a benzodiazepine antagonist.
37. 2026-10-02srcAlcohol after sedation with i.v. midazolam-fentanyl: effects on psychomotor functioning.
38. 2026-10-02srcAmnesia of the Operating Room in the B-Unaware and BAG-RECALL Clinical Trials.
39. 2026-10-02srcMidazolam: pharmacology and uses.
40. 2026-10-02srcUse of midazolam hydrochloride in anesthesia.
41. 2026-10-02srcPharmacokinetics of midazolam in anaesthetized cirrhotic patients.
42. 2026-10-02srcPharmacokinetics of midazolam used as an intravenous induction agent for patients over 80 years of age.
43. 2026-10-02srcSafety aspects of midazolam.
44. 2026-10-02srcEffect of age, gender, and obesity on midazolam kinetics.
45. 2026-10-02srcProlonged sedation due to accumulation of conjugated metabolites of midazolam.
46. 2026-10-02srcMidazolam - Wikipedia
47. 2026-10-02srcMidazolam FDA Approval History (Versed 1985, Nayzilam 2019)
48. 2026-09-04issueIssued emergency
49. 2026-09-04issueIssued info_card
50. 2026-09-04issueIssued notice
51. 2026-07-03proposaldependence · taper
52. 2026-06-04proposal43 value proposals approved togetherone review action inferred from a shared reviewer and instant — the graph records one activity per proposal
53. 2026-06-04publicationPublication — backfill
54. 2026-05-09revisionRevision 1
55. 2026-05-09absenceSearched PubMed for "midazolam history synthesis discovery imidazobenzodiazepine" — no results
56. 2026-05-09genGeneration — pipeline-v5 · with 3 morepipeline-v5
57. 2026-05-09rungeneration run

The same entries, as forms: six forms.